Back to search

Article

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study

2023-04-11

Abstract excerpt

<h4>Background</h4> Individuals with schizophrenia are at elevated genetic risks for comorbid cannabis use, and often experience exacerbations of cognitive and psychotic symptoms when exposed to cannabis. These findings have led a number of investigators to examine cannabinoid CB1 receptor (CB1R) alterations in schizophrenia, though with conflicting results. We recently demonstrated the presence of CB1R in both e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dad0b08c-b97b-51d4-9275-64252ab12180
DOI
10.1101/2023.04.11.536217
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot studyDOI 10.1101/2023.04.11.536217
Select a neighboring publication to make it the new centre.